Cetera Trust Company, N.A Care Dx, Inc. Transaction History
Cetera Trust Company, N.A
- $164 Billion
- Q3 2024
A detailed history of Cetera Trust Company, N.A transactions in Care Dx, Inc. stock. As of the latest transaction made, Cetera Trust Company, N.A holds 11,870 shares of CDNA stock, worth $286,185. This represents 0.23% of its overall portfolio holdings.
Number of Shares
11,870
Previous 11,870
-0.0%
Holding current value
$286,185
Previous $184 Million
101.06%
% of portfolio
0.23%
Previous 0.12%
Shares
1 transactions
Others Institutions Holding CDNA
# of Institutions
219Shares Held
51.1MCall Options Held
97.3KPut Options Held
43.3K-
Black Rock Inc. New York, NY5.29MShares$127 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.54MShares$109 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.15MShares$75.8 Million1.65% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.99MShares$72.1 Million0.89% of portfolio
-
State Street Corp Boston, MA2.04MShares$49.1 Million0.0% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.29B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...